Unlock instant, AI-driven research and patent intelligence for your innovation.

Vibrio parahaemolyticus gene deletion attenuated strain, recombinant vibrio parahaemolyticus attenuated live vaccine and preparation method and application thereof

A hemolytic Vibrio, gene deletion technology, applied in the biological field, can solve problems such as affecting health and food safety, drug residues, losses, etc.

Active Publication Date: 2021-07-02
浙江洪晟生物科技股份有限公司 +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current prevention and treatment of vibriosis is mainly to feed antibiotics, but this method has certain defects, such as the residue of drugs and the corresponding drug resistance of bacteria, which have become a threat to people's health. and food safety, which also led to poor quality and loss of some aquatic crops

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vibrio parahaemolyticus gene deletion attenuated strain, recombinant vibrio parahaemolyticus attenuated live vaccine and preparation method and application thereof
  • Vibrio parahaemolyticus gene deletion attenuated strain, recombinant vibrio parahaemolyticus attenuated live vaccine and preparation method and application thereof
  • Vibrio parahaemolyticus gene deletion attenuated strain, recombinant vibrio parahaemolyticus attenuated live vaccine and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0100] 6 Preparation of antiserum

[0101] 6.1 Use recombinant attenuated strains to immunize mice. Choose five mice each from the control group and the experimental group. The mice in the experimental group are subcutaneously injected with 106 CFU of recombinant attenuated strains every 7 days. The control group was injected with normal saline. A total of 4 immunizations were performed on the mice

[0102] 6.2 Take blood from mice to prepare antiserum After mice are immunized, insert a needle from the chest below the clavicle, puncture the jugular vein to take blood, and collect the blood into an EP tube. Put the EP tube in a 37°C incubator and place it in a 4°C refrigerator until the blood coagulates, then centrifuge the blood at 4°C and 3500rpm for 15 minutes to carefully absorb the upper layer of serum, and carefully store it at -80°C for future experiments use. At the same time, the serum of the control group was prepared as a control.

[0103] 7 Antiserum titer detec...

Embodiment 1

[0107] Example 1 successfully obtained virulence gene vcrD2 knockout strain (named VP3)

[0108] For the method of obtaining the strains with knockout tdhA and vcrD1 genes, please refer to the master’s thesis published by our laboratory (Zha Zhenzhong, Study on the regulation of host cell immune response by Vibrio parahaemolyticus effector protein VPA1324, Zhejiang Sci-Tech University, 2018).

[0109] 1 PCR amplification of vcrD2 upper and lower homology arm gene sequences and fusion PCR amplification of fusion gene fragments

[0110] According to the vcrD2 (VPA1355) gene sequence in the NCBI database, two primer pairs pRE112-ΔvcrD2-F1 / -R1 and pRE112-ΔvcrD2-F2 / -R2 were used to amplify the upper and downstream homology arm fragments of the gene respectively, and the results showed The two PCR products were respectively at 540bp and 320bp in the agarose gel ( figure 2 a, b). After recovery, use pRE112-ΔvcrD2-F1 / -R2 primers to perform fusion PCR to obtain the fusion fragment o...

Embodiment 2

[0119] Example 2 Successful construction of vector pBBR1MCS-1-ompA-lptD

[0120] 1PCR amplification of the lptD gene fragment and overlapping extension PCR to obtain the ompA-lptD gene fragment

[0121] According to the full gene sequence of lptD and the three-dimensional structure of lptD displayed on NCBI, using the VP bacteria genome as a template, use primers (see Table 2-1) to PCR amplify the 748bp-1343bp gene fragment (corresponding to the 249bp-781bp fragment of the lptD protein) ( Figure 7 a). The DNA sequence coupling (synthesizing) that has lptD fragment and the signal peptide of outer membrane protein OmpA then by overlap extension PCR, the result shows that successfully obtains the lptD gene fragment containing ompA signal sequence ( Figure 7 b). The resulting fusion gene fragment and the pBBR1MCS-1 plasmid need to be digested with the corresponding restriction endonucleases before the next step of the ligation experiment can be performed. The experimental res...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a vibrio parahaemolyticus gene deletion attenuated strain and a vaccine based on the vibrio parahaemolyticus gene deletion attenuated strain. The vibrio parahaemolyticus gene deletion attenuated strain disclosed by the invention is a strain which does not contain tdhA, vcrD1 and vcrD2 genes and efficiently expresses lptD protein on an outer membrane. The vaccine contains vibrio parahaemolyticus gene deletion attenuated strains and a pharmaceutically acceptable diluent, the content of the vaccine is that the strain concentration of each part is 108 CFU, and the diluent is a PBS buffer solution passing through a 0.22 [mu] m filter membrane or normal saline passing through a 0.22 [mu] m filter membrane. A safety experiment of the constructed vibrio parahaemolyticus gene-deleted attenuated strain shows that the toxicity of the strain is remarkably reduced, and the strain is non-toxic to experimental animals; immunoprotective analysis of the strain shows that the strain has an efficient immune protection effect, and experimental animals can be completely protected from death.

Description

technical field [0001] The invention relates to a gene-deleted attenuated strain of Vibrio parahaemolyticus, a recombinant live attenuated vaccine of Vibrio parahaemolyticus, a preparation method and application thereof, and belongs to the field of biotechnology. Background technique [0002] Vibrio, which is Gram-negative, is a halophilic bacterium that is widespread in areas near rivers and seawater. Vibriosis in fish, shrimp, shellfish, etc. caused by pathogenic Vibrio infection is the most important bacterial disease in aquaculture animals. Currently, 27 species of Vibrio have been found to cause vibriosis, among which Vibrio parahaemolyticus (V.parahaemolyticus) is the most common. Vibrio parahaemolyticus has brought potential harm to humans and various organisms. It not only endangers the healthy development of the aquaculture industry, but also makes fish and shrimp infected with bacterial diseases and dies, causing huge economic losses. It is also the main food sour...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/21C12N15/74A61K39/106A61P31/04C12R1/63
CPCC07K14/28C12N15/74A61K39/107A61P31/04A61K2039/522A61K2039/552A61K2039/575A61K2039/57
Inventor 潘建义高智超查振中查银河
Owner 浙江洪晟生物科技股份有限公司